Mimotope peptide modified pompon mum-like magnetic microparticles for precise recognition, capture and biotransformation analysis of rituximab in biological fluids.

Biotransformation Mimotope peptide Patient serum Peptide-based biomaterials Precise recognition Therapeutic monoclonal antibody

Journal

Acta pharmaceutica Sinica. B
ISSN: 2211-3835
Titre abrégé: Acta Pharm Sin B
Pays: Netherlands
ID NLM: 101600560

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 20 07 2023
revised: 25 09 2023
accepted: 17 10 2023
medline: 15 3 2024
pubmed: 15 3 2024
entrez: 15 3 2024
Statut: ppublish

Résumé

Due to low immobilized ligand density, limited binding capacity, and severe interference from serum proteins, developing ideal peptide-based biomaterials for precise recognition and

Identifiants

pubmed: 38487009
doi: 10.1016/j.apsb.2023.10.018
pii: S2211-3835(23)00412-4
pmc: PMC10935506
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1317-1328

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Auteurs

Jiawen Yang (J)

Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China.

Aixuan Zhou (A)

Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China.

Minyi Li (M)

Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China.

Qiaoxian He (Q)

Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China.

Jingwei Zhou (J)

Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China.

Jacques Crommen (J)

Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China.
Laboratory for the Analysis of Medicines, Department of Pharmaceutical Sciences, CIRM, University of Liege, Liege B-4000, Belgium.

Wentao Wang (W)

SCIEX, Shanghai 200050, China.

Zhengjin Jiang (Z)

Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China.
Laboratory for the Analysis of Medicines, Department of Pharmaceutical Sciences, CIRM, University of Liege, Liege B-4000, Belgium.

Qiqin Wang (Q)

Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China.
Laboratory for the Analysis of Medicines, Department of Pharmaceutical Sciences, CIRM, University of Liege, Liege B-4000, Belgium.

Classifications MeSH